Articles

An S&P 500 correction, or a possible meltdown in Asian currencies, could be brewing. Here’s why.

Our call of the day from TS Lombard flags worrying signs on the labor market, and Asian currencies that need things to go just right for the U.S. economy.

Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims

The plan is expected to resolve 99.75% of all pending talc lawsuits against the company and its units in the U.S., it said in a statement.

AMD’s mixed earnings reveal a company with a lot to prove — and the goods to do it

Why 2024 will be a year of sizeable growth for the chip maker.

Beating inflation will likely require an increase in the U.S. unemployment rate

Americans are on a frustrating search for a soft economic landing.

The U.S. birth rate has never been lower. Here’s what that means for stocks.

Americans aren’t having as many kids, but the economy can handle that — for now.

Adjustable-rate mortgage demand surges to highest level this year as 30-year rate keeps climbing

Mortgage applications fell 2.3% in the last week, the Mortgage Bankers Association said. The average rate for a 30-year mortgage is 7.29%.

Move over, meme-stock millennials. Your grandma wants to trade options.

Trading covered-call options on big stashes of stock can earn retirees extra income.

Oil prices fall after industry data points to rise in U.S. crude inventories

Oil futures are on track for a three-day losing streak.

Biden administration to cancel $6.1 billion in student debt for borrowers who were scammed by single school

The Department of Education is cancelling $6.1 billion worth of student debt for 317,000 borrowers who were scammed by their school, officials announced Wednesday.

Mini’s new all-electric Aceman looks fun, and in a category of its own

The 2025 Mini Aceman is sort of like a subcompact luxury hatchback. It’s larger than a Cooper and smaller than a Countryman.

The incredible homes of Taylor Swift’s ex-boyfriends (or tortured poets?)

From John Mayer’s Beverly Hills mansion to a chic Tribeca building where 2 of her rumored exes reside, we rounded up the real estate of Swift’s former romances.

GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line

The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022
1 1,400 1,401 1,402 1,403 1,404 2,503